Medicine guide

Dermacinrx Phn Pak

Kit

  • Prescription only
Active substance
Lidocaine
Made by
PureTek Corporation

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

At a glance

Quoted from the official label · 2024-12-06

The FDA lists a current shortage of lidocaine

Not necessarily this product — shortages are reported per presentation. Your pharmacy will know. · Updated 2026-09-22 FDA drug shortages

Used for
  • HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Lidocaine patch 5% safely and effectively.
Do not take it if

Lidocaine patch 5% is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product.

All warnings ↓
Good to know
  • Prescription only
  • FDA enforcement reports list no ongoing recall, and none from the last two years, for this product code · checked 2026-10-02
410other products contain Lidocaine — compare makers, forms and strengths

Every line above is selected, not written, from the official label. Nothing is reworded. DailyMed

What it is for

  • HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Lidocaine patch 5% safely and effectively.
  • See full prescribing information for Lidocaine patch 5%.
  • Lidocaine patch 5% is indicated for relief of pain associated with post-herpetic neuralgia.
  • It should be applied only to intact skin.
  • Lidocaine patch 5% is indicated for relief of pain associated with post-herpetic neuralgia.
  • It should be applied only to intact skin.

From the official label · 2024-12-06 · DailyMed

How it works

From this product’s own US prescribing label.

CLINICAL PHARMACOLOGY

Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2024-12-06

Do not take it if

Lidocaine patch 5% is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product.

Quoted from the official label, section “Contraindications”.

How to take it

These directions are for this exact strength and form. Another one is different.

  • Apply lidocaine patch 5% to intact skin to cover the most painful area.
  • Apply the prescribed number of patches (maximum of 3), only once for up to 12 hours within a 24-hour period.
  • Patches may be cut into smaller sizes with scissors prior to removal of the release liner.
  • (See HANDLING AND DISPOSAL) Clothing may be worn over the area of application.
  • Smaller areas of treatment are recommended in a debilitated patient, or a patient with impaired elimination.
  • If irritation or a burning sensation occurs during application, remove the patch(es) and do not reapply until the irritation subsides.
  • When lidocaine patch 5% is used concomitantly with other products containing local anesthetic agents, the amount absorbed from all formulations must be considered.
  • Lidocaine patch 5% may not stick if it gets wet.
  • Avoid contact with water, such as bathing, swimming or showering.

Quoted from the official label, section “Dosage & Administration”.

Other warnings

  • General Hepatic Disease:
  • Patients with severe hepatic disease are at greater risk of developing toxic blood concentrations of lidocaine, because of their inability to metabolize lidocaine normally.
  • Allergic Reactions:
  • Patients allergic to para-aminobenzoic acid derivatives (procaine, tetracaine, benzocaine, etc.) have not shown cross sensitivity to lidocaine.
  • However, lidocaine patch 5% should be used with caution in patients with a history of drug sensitivities, especially if the etiologic agent is uncertain.
  • Non-intact Skin:
  • Application to broken or inflamed skin, although not tested, may result in higher blood concentrations of lidocaine from increased absorption.
  • Lidocaine patch 5% is only recommended for use on intact skin.
  • External Heat Sources:
  • Placement of external heat sources, such as heating pads or electric blankets, over lidocaine patch 5% is not recommended as this has not been evaluated and may increase plasma lidocaine levels.
  • Eye Exposure:
  • The contact of lidocaine patch 5% with eyes, although not studied, should be avoided based on the findings of severe eye irritation with the use of similar products in animals.
  • If eye contact occurs, immediately wash out the eye with water or saline and protect the eye until sensation returns.

Quoted from the official label, section “Warnings”.

Pregnancy and breastfeeding

  • Teratogenic Effects: Pregnancy Category B.
  • Lidocaine patch 5% has not been studied in pregnancy.
  • Reproduction studies with lidocaine have been performed in rats at doses up to 30 mg/kg subcutaneously and have revealed no evidence of harm to the fetus due to lidocaine.
  • There are, however, no adequate and well-controlled studies in pregnant women.
  • Because animal reproduction studies are not always predictive of human response, lidocaine patch 5% should be used during pregnancy only if clearly needed.
  • Lidocaine patch 5% has not been studied in nursing mothers. Lidocaine is excreted in human milk, and the milk:plasma ratio of lidocaine is 0.4. Caution should be exercised when lidocaine patch 5% is administered to a nursing woman.

Quoted from the official label, section “OTC — Pregnancy or Breast Feeding”.

Other medicines

  • Antiarrhythmic Drugs:
  • Lidocaine patch 5% should be used with caution in patients receiving Class I antiarrhythmic drugs (such as tocainide and mexiletine) since the toxic effects are additive and potentially synergistic.
  • Local Anesthetics :
  • When lidocaine patch 5% is used concomitantly with other products containing local anesthetic agents, the amount absorbed from all formulations must be considered.

Quoted from the official label, section “Drug Interactions”.

If you take too much

In an emergency, call your local emergency number or a poison control centre.

  • Lidocaine overdose from cutaneous absorption is rare, but could occur.
  • If there is any suspicion of lidocaine overdose (see ADVERSE REACTIONS, Systemic Reactions), drug blood concentration should be checked.
  • The management of overdose includes close monitoring, supportive care, and symptomatic treatment.
  • Dialysis is of negligible value in the treatment of acute overdose with lidocaine.
  • In the absence of massive topical overdose or oral ingestion, evaluation of symptoms of toxicity should include consideration of other etiologies for the clinical effects, or overdosage from other sources of lidocaine or other local anesthetics.
  • The oral LD50 of lidocaine HCl is 459 (346 to 773) mg/kg (as the salt) in non-fasted female rats and 214 (159 to 324) mg/kg (as the salt) in fasted female rats, which are equivalent to roughly 4000 mg and 2000 mg, respectively, in a 60 to 70 kg man based on the equivalent surface area dosage conversion factors between species.

Quoted from the official label, section “Overdosage”.

Use in children

Safety and effectiveness in pediatric patients have not been established.

Quoted from the official label, section “Pediatric Use”.

What it looks like and how it is packed

  • Lidocaine patch 5% is available as the following:
  • Carton of 15 patches, NDC 59088-396-82 Carton of 30 patches, NDC 59088-396-54 Each patch is packaged into an individual child-resistant envelope (NDC 59088-396-84).
  • Store at 20o to 25oC (68o to 77oF) [See USP Controlled Room Temperature].
  • For more information, call Actavis at 1-800-272-5525.
  • Manufactured by: Actavis Laboratories UT, Inc.
  • Salt Lake City, UT 84108 USA Distributed by:
  • PureTek Corporation San Fernando, CA 91340 USA Rev. 37780 02/16

Quoted from the official label, section “How Supplied”.

What is in it

  • Lidocaine patch 5% is comprised of an adhesive material containing 5% lidocaine, which is applied to a white non-woven polyethylene terephthalate (PET) material backing and covered with a transparent PET release liner.
  • The release liner is removed prior to application to the skin.
  • The size of the patch is 10 cm x 14 cm.
  • Lidocaine is chemically designated as acetamide, 2-(diethylamino)-N-(2,6-dimethylphenyl), has an octanol:water partition ratio of 43 at pH 7.4, and has the following structure:
  • Each adhesive patch contains 700 mg of lidocaine (50 mg per gram adhesive) in an aqueous base.
  • It also contains the following inactive ingredients:
  • glycerin, D-sorbitol, propylene glycol, polyvinyl alcohol, urea, sodium polyacrylate, carboxymethylcellulose sodium, gelatin, polyacrylic acid, kaolin, tartaric acid, dihydroxyaluminum aminoacetate, methylparaben, propylparaben, and edetate disodium.
  • Lidocaine-Structure

Quoted from the official label, section “Description”.

Ingredients people check for

Lactose, gluten, dyes, sugars and other ingredients that matter with an allergy, intolerance or diet — as this product’s FDA label lists them.

  • Sugar alcoholsD-sorbitolSorbitol and similar can upset the stomach and matter with fructose intolerance.
  • GelatingelatinAnimal-derived: matters for vegetarian, vegan, halal and kosher diets.
  • Parabensmethylparaben; propylparabenPreservatives some people prefer to avoid or are sensitive to.

Quoted from the FDA label. A label that does not name an ingredient is not a guarantee that the product is free of it, and formulations change. With an allergy, check the pack and ask a pharmacist.

Every version of this medicine (19)

The same active substance, strength and kind of form, from every company that sells it — with what each label lists.

Hide versions whose label lists:

Showing 19 of 19

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

CanadaNo exact match for this strength and form

Details

Made byPureTek Corporation
Active substanceLidocaine
FormKit
Packs1 KIT in 1 KIT * 15 POUCH in 1 CARTON / .7 g in 1 POUCH
NDC59088-807

Source: NDC Directory · 2026-09-13 · not reviewed by a clinician

Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.